Ionis Pharmaceuticals' (IONS) CEO Brett Monia on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/26/20
Ionis Pharmaceuticals (IONS) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/26/20
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia TreatmentThe Motley Fool • 01/29/20
Akcea and Ionis' Triglyceride-Lowering Drug Works in Mid-Stage Clinical TrialThe Motley Fool • 01/22/20
Will These Biotechs Rival A Top-Notch Stock In High Triglycerides?Investors Business Daily • 01/22/20
Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid CardiomyopathyGlobeNewsWire • 01/10/20
Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR AmyloidosisGlobeNewsWire • 11/25/19
Surging Earnings Estimates Signal Upside for Ionis Pharmaceuticals (IONS) StockZacks Investment Research • 11/20/19
Ionis Pharmaceuticals, Inc. (IONS) Management Presents at Stifel 2019 Healthcare Conference (Transcript)Seeking Alpha • 11/19/19
Ionis Pharmaceuticals, Inc. (IONS) CEO Stanley Crooke on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/07/19
Here's One Drugmaker That Popped On Earnings — And Two That Didn'tInvestors Business Daily • 11/06/19
Ionis Pharmaceuticals (IONS) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/06/19
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/30/19